RetinaCME
GAMINGCMEABO MOC

Age-Related Macular Degeneration (AMD): A Closer Look at Treatment Regimens, Dosing, and Fluid Considerations—A Wheel of Knowledge Challenge

Author(s)/Faculty: Arshad M. Khanani, MD, MA
Release Date: 3/31/2021Expiration Date: 3/30/2022
Credit Type: CME / CME with ABO Continuing Certification Number of Credits: 0.5
Content Type: GamingProvider:
Pinnacle clinical studies evaluating the management of neovascular age-related macular degeneration (nAMD) with anti-vascular endothelial growth factor (VEGF) therapies have demonstrated significant visual acuity gains. However, these same visual acuity gains are not always observed in real-world studies due to undertreatment or lack of patient adherence associated with treatment burden. The continued refinement of treatment dosing regimens and the personalized extension of treatment intervals have the potential to overcome treatment burden and undertreatment while enhancing long-term visual outcomes. In this Wheel of Knowledge Challenge, an interactive quiz of knowledge and confidence, your knowledge will be tested on the treatment burden of anti-VEGF therapies, the impact of retinal fluid on visual outcomes, and dosing of anti-VEGF therapies in the long-term management of nAMD.